[1]
M. Yassen, “The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients with Symptomatic Hypertrophic Cardiomyopathy”, Translation, vol. 11, no. 1, May 2023, doi: 10.46570/utjms.vol11-2023-727.